BRAF and melanoma: Consistent with prior observations in the Tyr-CreER:Braf:Pten model5,6, Braf:Pten mutations during the telogen resting phase did not induce melanoma initiation from McSCs in either c-Kit or Tyr-driven model (Fig. 3a bottom, c; Supplementary Fig. 4a–f).